MedPath

Prospective Multicentric Trial Between Radiofrequency Ablation With VNUS Closure Fast ® and Endovenous Ablation With 1470 nm Diode Laser and Tulip Fiber ® for Treatment of Primary Venous Insufficiency.

Not Applicable
Completed
Conditions
Chronic Venous Insufficiency C2 or Higher
Interventions
Device: Tulip fiber
Device: VNUS closure fast
Registration Number
NCT01722019
Lead Sponsor
University Hospital, Ghent
Brief Summary

Endovenous ablation of the greater saphenous vein has nowadays the same outcome as open crossectomy and stripping. The two most performed techniques for endovenous ablation are the endovenous laser ablation and the radiofrequency ablation. According to the trial of Rasmussen, they are equivalent for occlusion but the lower laser wave lengths resulted in more pain and paresthesia. The newer wave length of 1470 nm showed lesser side effects in observational studies. The aim of this study is to compare radiofrequency ablation with the VNUS closure fast ® with laser ablation with a 1470 nm wave length in combination with a new fiber, the Tulip fiber ®. This fiber has the shape of a tulip at his tip which avoids point necroses of the vessel wall and on consequence results in lesser side effects from wall perforations such as pain, haematoma,...

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
280
Inclusion Criteria
  • Endovenous ablation of the great saphenous vein (GSV) planned
  • Patient signed informed consent
  • Patient must complete the 1 year follow-up
  • CEAP between 2 and 6
  • BMI=<35
  • Diameter of the GSV in upward position less than 20 mm diameter
  • No problems in deep venous system
Exclusion Criteria
  • No informed consent is signed
  • Latex allergy
  • Arterial insufficiency
  • Deep vein thrombosis or deep vein insufficiency
  • Klippel Trenaunay
  • Diameter fo GSV > 20 mm
  • Cross dilation with 2 or more insufficient side branches
  • Previous GSV operation
  • Redo-operation
  • Carcinoma less than 1 year ago
  • BMI > 35
  • Liver-insufficiency with contraindication for local tumescence
  • Intake of warfarins
  • Pregnancy, breastfeeding, < 3 months after pregnancy
  • Bilateral GSV insufficiency that has to be treated
  • Cross insufficiency of the accessory saphenous vein or insufficiency of the subterminal valve of the GSV

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
laser ablation and Tulip fiberTulip fiberLaser ablation with a 1470 nm wave length in combination with a new fiber, the Tulip fiber.
radiofrequency ablation with VNUS closure fastVNUS closure fastRadiofrequency ablation will be performed with VNUS closure fast.
Primary Outcome Measures
NameTimeMethod
Closure of the greater saphenous vein at 12 months.12 months after procedure

Closure of the greater saphenous vein will be measured by venous duplex, Kabnick score and modified Gelev score. This will be performed after 5 days, 1 month, 6 months and 12 months.

Secondary Outcome Measures
NameTimeMethod
Pain.after 1 year.

This will be measured with the VAS score, VCSS score, CIVIQ score, clinical evaluation and hematoma score.

Incapacity to work.After 1 year

This will be measured with the VAS score, VCSS score, CIVIQ score, clinical evaluation and hematoma score.

Patient satisfaction rate.After 1 year.

This will be measured with the VAS score, VCSS score, CIVIQ score, clinical evaluation and hematoma score.

Pain satisfaction rate.After 6 months

This will be measured with the VAS score, VCSS score, CIVIQ score, clinical evaluation and hematoma score.

Trial Locations

Locations (3)

Ghent University Hospital

🇧🇪

Ghent, Belgium

University Hospital Leuven

🇧🇪

Leuven, Belgium

Sint-Andriesziekenhuis Tielt

🇧🇪

Tielt, Belgium

© Copyright 2025. All Rights Reserved by MedPath